The classification of asset and income figures as well as of other key figures by business sector or by region in accordance with IAS 14 is presented in “Segment Reporting”. Segmentation was performed in accordance with the internal reporting of the Merck Group. The financial result and taxes on income are allocated in full in the Corporate and Other segment. The operating segments are described in detail in the chapter about the divisions in this Annual Report.
Transfer prices for intragroup sales are determined on an arm’s-length basis. There were no significant intercompany relations between the business segments. In the Segment Reporting, the United States and Canada are combined to form a single region “North America”, as the two countries are managed as a single territory in the Merck Group’s internal reporting.
The reconciliation of operating assets included in “Segment Reporting” is as follows:
| XLS |
|
€ million |
Dec. 31, 2008 |
Dec. 31, 2007 |
|
Assets |
15,644.7 |
14,922.3 |
|
Monetary assets (cash and equivalents, loans, securities) |
–895.7 |
–1,020.5 |
|
Non-operating receivables, tax receivables, deferred taxes |
–664.2 |
–567.0 |
|
Trade accounts payable |
–843.7 |
–646.9 |
|
Other operating liabilities |
–472.9 |
–481.1 |
|
Operating assets of discontinued operations |
– |
–26.9 |
|
Operating assets |
12,768.2 |
12,179.9 |
The Merck Serono division accounted for € 0.7 million (2007: € 0.3 million) and the Performance & Life Science Chemicals division for € 0.2 million (2007: € 0.2 million) of the investment result disclosed in the income statement. Losses of € 0.8 million were attibutable to the segment Corporate and Other in 2008 (2007: € 0.2 million).
back
